Donaldson, C., Hundley, V. and McIntosh, E. (1996) Using economics alongside clinical trials: why we cannot choose the evaluation technique in advance. Health Economics, 5(3), pp. 267-269.
Full text not currently available from Enlighten.
Abstract
When drafting protocols for the use of economic evaluation alongside clinical trials, it is common to have to specify which type of economic evaluation is going to be carried out. Will it be a cost-benefit analysis (CBA), cost-effectiveness analysis (CEA) or a cost-utility analysis (CUA)? It is our contention that prior specification of the appropriate economic technique is not possible, in the majority of cases, until data on effectiveness and cost are actually available. In this letter, we aim to demonstrate the thinking behind our contention and to illustrate this with two case studies; one of a recent randomised trial, the other of a trial currently in progress.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | McIntosh, Professor Emma |
| Authors: | Donaldson, C., Hundley, V., and McIntosh, E. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Health Economics and Health Technology Assessment |
| Journal Name: | Health Economics |
| ISSN: | 1057-9230 |
| ISSN (Online): | 1099-1050 |
| Related URLs: |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details